Nuclear receptors provide therapeutic potential in a range of disease types, including cardiovascular, CNS, inflammation and oncology, and continue to be attractive drug targets. Our team has worked on a wide range of targets in each of these therapeutic areas and is available to progress your nuclear receptor-based project further, whether starting from conventional high-throughput screening or using a structural biology approach.

Our integrated team can help progress your project towards the clinic and have previously delivered candidate drugs to our partners for inflammation, respiratory and CNS indications.